FFIV vs LAB · P/E 32, rev $3.09B vs rev $174.4M
F5 Networks Inc (FFIV) versus Standard Biotools Inc (LAB) — a side-by-side from cached financials, not a winner call.
F5 Networks Inc (FFIV) is a software - infrastructure company listed on NASDAQ.
Standard Biotools Inc (LAB) is a medical devices company listed on NASDAQ.
Latest reported FFIV revenue for 2025-09-30 was $3.09B. Net income was $692.4M. Revenue was up 9.7% from 2024-09-30 to 2025-09-30. FFIV currently screens at market cap $21.71B and trailing P/E 31.6.
Latest reported LAB revenue for 2024-12-31 was $174.4M. Net income was -$138.9M. Revenue was up 64.0% from 2023-12-31 to 2024-12-31. LAB currently screens at market cap $317.1M.
FFIV currently screens at market cap $21.71B and trailing P/E 31.6. LAB currently screens at market cap $317.1M.
Not investment advice. Open the FFIV and LAB stock pages for the full models.
Not investment advice.